Surrogate end points in clinical trials: are we being misled?
Fleming
T R
TR
Department of Biostatistics, University of Washington, Seattle 98195-7232, USA.
DeMets
D L
DL
D017322:Clinical Trials, Phase II as Topic / Q000379:methods / Q000592:standards; D017326:Clinical Trials, Phase III as Topic / Q000379:methods* / Q000592:standards*; D006801:Humans